XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Redeemable Convertible Preferred Stock
Preferred Investment Options
Common Stock
Preferred Investment Options
Additional Paid-In Capital
Preferred Investment Options
Placement Agents Warrants
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Temporary equity, beginning balance at Dec. 31, 2021 $ 15,246                
Temporary equity, beginning balance (in shares) at Dec. 31, 2021 5,012,280                
Balance at the beginning at Dec. 31, 2021             $ 1,892 $ (12,900) $ (11,008)
Balance at the beginning (in shares) at Dec. 31, 2021           4,505,514      
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT                  
Conversion of Series A redeemable convertible preferred shares $ (15,246)                
Conversion of Series A redeemable convertible preferred shares (in shares) (5,012,280)                
Conversion of Series A redeemable convertible preferred shares             15,246   15,246
Conversion of Series A redeemable convertible preferred shares (in shares)           5,012,280      
Issuance of common stock upon initial public offering, net of offering costs of $2,892 - At-the-market             13,108   13,108
Issuance of common stock upon initial public offering, net of offering costs of $2,892 - At-the-market (in shares)           3,200,000      
Share based payments             156   156
Net loss for the period               (2,943) (2,943)
Balance at the end at Mar. 31, 2022             30,402 (15,843) 14,559
Balance at the end (in shares) at Mar. 31, 2022           12,717,794      
Temporary equity, beginning balance at Dec. 31, 2021 $ 15,246                
Temporary equity, beginning balance (in shares) at Dec. 31, 2021 5,012,280                
Balance at the beginning at Dec. 31, 2021             1,892 (12,900) (11,008)
Balance at the beginning (in shares) at Dec. 31, 2021           4,505,514      
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT                  
Net loss for the period                 (6,512)
Balance at the end at Jun. 30, 2022             30,912 (19,412) 11,500
Balance at the end (in shares) at Jun. 30, 2022           12,717,794      
Balance at the beginning at Mar. 31, 2022             30,402 (15,843) 14,559
Balance at the beginning (in shares) at Mar. 31, 2022           12,717,794      
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT                  
Share based payments             510   510
Net loss for the period               (3,569) (3,569)
Balance at the end at Jun. 30, 2022             30,912 (19,412) 11,500
Balance at the end (in shares) at Jun. 30, 2022           12,717,794      
Balance at the beginning at Dec. 31, 2022             46,204 (31,985) 14,219
Balance at the beginning (in shares) at Dec. 31, 2022           15,190,720      
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT                  
Share based payments             1,402   1,402
Issuance of restricted stock awards (in shares)           585,499      
Exercise of warrants     $ 39 $ 39     663   663
Exercise of warrants (in shares)   4,000       105,920      
Net loss for the period               (4,049) (4,049)
Balance at the end at Mar. 31, 2023             48,308 (36,034) 12,274
Balance at the end (in shares) at Mar. 31, 2023           15,886,139      
Balance at the beginning at Dec. 31, 2022             46,204 (31,985) $ 14,219
Balance at the beginning (in shares) at Dec. 31, 2022           15,190,720      
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT                  
Exercise of warrants (in shares)       1,001,091 79,104        
Exercise of stock options (in shares)                 2,792
Net loss for the period                 $ (9,757)
Balance at the end at Jun. 30, 2023             62,074 (41,742) 20,332
Balance at the end (in shares) at Jun. 30, 2023           17,221,113      
Balance at the beginning at Mar. 31, 2023             48,308 (36,034) 12,274
Balance at the beginning (in shares) at Mar. 31, 2023           15,886,139      
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT                  
Issuance of common stock upon initial public offering, net of offering costs of $2,892 - At-the-market             3,110   3,110
Issuance of common stock upon initial public offering, net of offering costs of $2,892 - At-the-market (in shares)           188,970      
Share based payments             950   950
Issuance of restricted stock awards (in shares)           63,000      
Exercise of warrants     $ 8,852 $ 8,852     816   816
Exercise of warrants (in shares)   997,091       79,104      
Exercise of stock options             38   38
Exercise of stock options (in shares)           6,809      
Net loss for the period               (5,708) (5,708)
Balance at the end at Jun. 30, 2023             $ 62,074 $ (41,742) $ 20,332
Balance at the end (in shares) at Jun. 30, 2023           17,221,113